Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
The cancer drug Vecade (bortezomib) combined with glucocorticoids could be a treatment option for people with drug-resistant lupus nephritis (LN), suggests a study published in the scientific journal Lupus.
Patients with one autoimmune disease should be closely monitored because they may have a higher risk of developing another autoimmune disease according to a study published in the journal ... Read more
The flu vaccine is effective and associated with a lower risk of hospitalization, pneumonia, admission to the intensive care unit, in-hospital dialysis, and death in people with systemic lupus ... Read more
Maintaining optimal levels of vitamin D in the blood could be protective against the risk of cardiovascular disease often seen in systemic lupus erythematosus (SLE) patients, according to a ... Read more
Autoantibodies that naturally occur in the body of a population of patients with an ultra-rare type of autoimmune disorder called autoimmune polyendocrine syndrome type 1 (APS1 or APECED), could ... Read more
Ten marker genes related to systemic lupus erythematosus (SLE) were identified from three different types of blood samples. These genes may have the potential to be used as biomarkers ... Read more
Pin It on Pinterest